Skip to Content

Markets
Technicals
Companies
Earnings
Close-Up
Themes

News

Market and company headlines

Loading

A personal project for following the US markets. Free, ad-free and open source.

Weekly Recap

Every Sunday morning: the week's earnings behind you and the calendar ahead, in one email.

Get It by Email

Market

Markets
Companies
Stock Screener
Macro
Earnings
Technical Analysis
Calendar
Compare
Thematic Lists
Famous Investors

Reading

Guide
Close-Up
Community
News
Brief Archive
Glossary
Tax Calculator
RSS

Account

Watchlist
My Posts
Bell Report
Portfolio
Settings
Privacy

© 2026 Opening BellPrivacy About What's New ContactNot Investment AdviceAhmet Akyapı

Markets Earnings Close-Up Menu

Nasdaq 100 · QQQ721.22+ 1.27%S&P 500 · SPY769.93+ 0.60%Dow Jones · DIA523.42+ 0.09%Russell 2000 · IWM280.07+ 1.11%

111, Inc. Announces Establishment of the Special Committee
111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directors, Mr. Jian Sun, who is the chairman of the Special Committee, Mr. Nee Chuan Teo and Mr. Jun Luo, has been established by the Company's Board of Directors to consider and evaluate the previously announced preliminary, non-binding proposal letter dated September 16, 2026 (the "Pr
Yahoo04:3029 Days AgoYI

04:00Sep 172 Stories

111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding proposal letter (the "Proposal") dated September 16, 2026 jointly submitted by Dr. Gang Yu, co-founder and co-chairman of the Company, Mr. Junling Liu, co-founder, co-chairman and chief executive officer of the Company (collectively, the "Co-Founders") and Huadeng Tech BioArray V
Yahoo04:25YI
China's 111 Inc. Gets Buyout Proposal From Co-Founders in Going-Private Push
111 Inc. (YI) reports Q2 2026 results with widened net loss, a shift to asset-light model, and an unsolicited $4.52/ADS privatization bid.
Benzinga04:14YI

03:00Sep 171 Story

111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the second quarter ended June 30, 2026.
Yahoo03:00YI

23:00Sep 161 Story

111 Q2 Adj. EPS $(0.60) Down From $(0.40) YoY, Sales $338.995M Down From $447.507M YoY
111 (NASDAQ:YI) reported quarterly losses of $(0.60) per share. This is a 50 percent decrease over losses of $(0.40) per share from the same period last year. The company reported $338.995 million in sales this
Benzinga23:12YI